top of page


We've partnered with Dr. Mark Schultz and the Schultz Laboratory at the University of Iowa Stead Family Children's Hospital to research and develop a new gene therapy using the latest mRNA technology.

University of Iowa
Stead Family
Children's Hospital

Children with Niemann Pick Type-C are missing the NPC1 proteins which are responsible for breaking down and clearing out of cholesterol from the cells of the body.  If the cholesterol builds up enough, the cell will inevitably die.  When this happens in the brain and nervous system it causes neurodegeneration.  


The new gene therapy that we are researching & developing leverages new advancements in mRNA technology and medicines to help the body produce the missing NPC1 proteins so the cells can break down and clear out the cholesterol.  

If this gene therapy is successful children with Niemann Pick Type-C would be functionally cured of the disease by receiving regular doses of the treatment.

bottom of page